Cargando…
MiR-193b as an effective biomarker in human cancer prognosis for Asian patients: a meta-analysis
BACKGROUND: MiR-193b has been widely investigated in the last few years and an aberrant association has been observed between its expression levels and the prognosis of several human malignancies. We performed a meta-analysis to evaluate the prognostic effect of miR-193b on human cancers. METHODS: P...
Autores principales: | Yu, Hao, Peng, Yizhong, Wu, Zhipeng, Wang, Minjie, Jiang, Xiaobing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372259/ https://www.ncbi.nlm.nih.gov/pubmed/35966293 http://dx.doi.org/10.21037/tcr-21-2557 |
Ejemplares similares
-
Tissue miR-193b as a Novel Biomarker for Patients with Ovarian Cancer
por: Li, Haiyan, et al.
Publicado: (2015) -
MiR‐193b deregulation is associated with Parkinson's disease
por: Baghi, Masoud, et al.
Publicado: (2021) -
Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma
por: Grossi, Ilaria, et al.
Publicado: (2016) -
Upregulation of miR‐9 and miR‐193b over human Th17 cell differentiation
por: Shirani, Fahimeh, et al.
Publicado: (2020) -
MiR193a Modulation and Podocyte Phenotype †
por: Jha, Alok, et al.
Publicado: (2020)